BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24865236)

  • 1. The cyclin-dependent kinase inhibitor SNS-032 induces apoptosis in breast cancer cells via depletion of Mcl-1 and X-linked inhibitor of apoptosis protein and displays antitumor activity in vivo.
    Xie G; Tang H; Wu S; Chen J; Liu J; Liao C
    Int J Oncol; 2014 Aug; 45(2):804-12. PubMed ID: 24865236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is highly synergistic with cytarabine.
    Walsby E; Lazenby M; Pepper C; Burnett AK
    Leukemia; 2011 Mar; 25(3):411-9. PubMed ID: 21212792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia.
    Chen R; Wierda WG; Chubb S; Hawtin RE; Fox JA; Keating MJ; Gandhi V; Plunkett W
    Blood; 2009 May; 113(19):4637-45. PubMed ID: 19234140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Undecylprodigiosin selectively induces apoptosis in human breast carcinoma cells independent of p53.
    Ho TF; Ma CJ; Lu CH; Tsai YT; Wei YH; Chang JS; Lai JK; Cheuh PJ; Yeh CT; Tang PC; Tsai Chang J; Ko JL; Liu FS; Yen HE; Chang CC
    Toxicol Appl Pharmacol; 2007 Dec; 225(3):318-28. PubMed ID: 17881028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional inhibition by CDK7/9 inhibitor SNS-032 suppresses tumor growth and metastasis in esophageal squamous cell carcinoma.
    Zeng H; Yang H; Song Y; Fang D; Chen L; Zhao Z; Wang C; Xie S
    Cell Death Dis; 2021 Nov; 12(11):1048. PubMed ID: 34741018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples.
    Conroy A; Stockett DE; Walker D; Arkin MR; Hoch U; Fox JA; Hawtin RE
    Cancer Chemother Pharmacol; 2009 Sep; 64(4):723-32. PubMed ID: 19169685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DC120, a novel and potent inhibitor of AKT kinase, induces tumor cell apoptosis and suppresses tumor growth.
    Deng R; Yang F; Chang SH; Tang J; Qin J; Feng GK; Ding K; Zhu XF
    Mol Pharmacol; 2012 Aug; 82(2):189-98. PubMed ID: 22553359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway.
    Cao W; Li XQ; Wang X; Fan HT; Zhang XN; Hou Y; Liu SB; Mei QB
    Phytomedicine; 2010 Jul; 17(8-9):598-605. PubMed ID: 20092988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells.
    Kuo PL; Chen CY; Hsu YL
    Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling.
    Park SK; Sanders BG; Kline K
    Breast Cancer Res Treat; 2010 Nov; 124(2):361-75. PubMed ID: 20157774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riccardin D, a macrocyclic bisbibenzy, inhibits human breast cancer growth through the suppression of telomerase activity.
    Sun CC; Xu HM; Yuan Y; Gao ZH; Lou HX; Qu XJ
    Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):488-98. PubMed ID: 24836118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
    Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM
    Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local anesthetics induce apoptosis in human breast tumor cells.
    Chang YC; Liu CL; Chen MJ; Hsu YW; Chen SN; Lin CH; Chen CM; Yang FM; Hu MC
    Anesth Analg; 2014 Jan; 118(1):116-24. PubMed ID: 24247230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway.
    Elumalai P; Gunadharini DN; Senthilkumar K; Banudevi S; Arunkumar R; Benson CS; Sharmila G; Arunakaran J
    Toxicol Lett; 2012 Nov; 215(2):131-42. PubMed ID: 23089555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis.
    Patel V; Senderowicz AM; Pinto D; Igishi T; Raffeld M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS
    J Clin Invest; 1998 Nov; 102(9):1674-81. PubMed ID: 9802881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis.
    Wittmann S; Bali P; Donapaty S; Nimmanapalli R; Guo F; Yamaguchi H; Huang M; Jove R; Wang HG; Bhalla K
    Cancer Res; 2003 Jan; 63(1):93-9. PubMed ID: 12517783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SZ-685C, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the Akt/FOXO pathway.
    Xie G; Zhu X; Li Q; Gu M; He Z; Wu J; Li J; Lin Y; Li M; She Z; Yuan J
    Br J Pharmacol; 2010 Feb; 159(3):689-97. PubMed ID: 20128807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells.
    Kim HR; Park CG; Jung JY
    Int J Mol Med; 2014 Feb; 33(2):317-24. PubMed ID: 24285354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G1 arrest and apoptosis.
    Tsai SL; Suk FM; Wang CI; Liu DZ; Hou WC; Lin PJ; Hung LF; Liang YC
    Biochem Pharmacol; 2007 Dec; 74(11):1575-86. PubMed ID: 17869226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.